Log in to save to my catalogue

INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adoles...

INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adoles...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A704292921

INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes

About this item

Full title

INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes

Publisher

BioMed Central Ltd

Journal title

Trials, 2022, Vol.23 (1)

Language

English

Formats

Publication information

Publisher

BioMed Central Ltd

More information

Scope and Contents

Contents

The INNODIA consortium has established a pan-European infrastructure using validated centres to prospectively evaluate clinical data from individuals with newly diagnosed type 1 diabetes combined with centralised collection of clinical samples to determine rates of decline in beta-cell function and identify novel biomarkers, which could be used for...

Alternative Titles

Full title

INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A704292921

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A704292921

Other Identifiers

ISSN

1745-6215

E-ISSN

1745-6215

DOI

10.1186/s13063-022-06259-z

How to access this item